Abacavir compound sulfate, identified by the chemical designation 188062-50-2, represents a crucial nucleoside reverse inhibitor utilized in the therapy of HIV diseases. Its structural weight is approximately 359.36 g/mol, exhibiting a crystalline structure and a moderate dissolving capacity. The key ingredient functions by inhibiting the viral fac